613 related articles for article (PubMed ID: 17138497)
1. Use of health-related quality of life information in managed care formulary decision-making.
Wu WK; Sause RB; Zacker C
Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
[TBL] [Abstract][Full Text] [Related]
2. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans.
Ganther-Urmie JM; Nair KV; Valuck R; McCollum M; Lewis SJ; Turpin RS
Am J Manag Care; 2004 Mar; 10(3):201-8. PubMed ID: 15032257
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life measurements and studies in rheumatoid arthritis.
Lubeck DP
Am J Manag Care; 2002 Sep; 8(9):811-20. PubMed ID: 12234022
[TBL] [Abstract][Full Text] [Related]
4. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
Bukstein DA
Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
[TBL] [Abstract][Full Text] [Related]
5. Weighing the evidence: trends in managed care formulary decision making.
de Lissovoy G
J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
[TBL] [Abstract][Full Text] [Related]
6. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
Segal R; Pathak DS
Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
[TBL] [Abstract][Full Text] [Related]
7. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
Fry RN; Avey SG; Sullivan SD
Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
[TBL] [Abstract][Full Text] [Related]
8. Do drug formulary policies reflect evidence of value?
Neumann PJ; Lin PJ; Greenberg D; Berger M; Teutsch S; Mansley E; Weinstein MC; Rosen AB
Am J Manag Care; 2006 Jan; 12(1):30-6. PubMed ID: 16402886
[TBL] [Abstract][Full Text] [Related]
9. Involvement in decision-making and breast cancer survivor quality of life.
Andersen MR; Bowen DJ; Morea J; Stein KD; Baker F
Health Psychol; 2009 Jan; 28(1):29-37. PubMed ID: 19210015
[TBL] [Abstract][Full Text] [Related]
10. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
Giraldes Mdo R
Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
[TBL] [Abstract][Full Text] [Related]
11. Results of our national survey. Current formulary decision-making strategies and new factors influencing the process.
Formulary; 1995 Aug; 30(8):462-70. PubMed ID: 10151734
[TBL] [Abstract][Full Text] [Related]
12. Incorporating clinical outcomes and economic consequences into drug formulary decisions: a practical approach.
Mather DB; Sullivan SD; Augenstein D; Fullerton DS; Atherly D
Am J Manag Care; 1999 Mar; 5(3):277-85. PubMed ID: 10351024
[TBL] [Abstract][Full Text] [Related]
13. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: results of a small survey of managed care organizations and pharmaceutical manufacturers.
Nichol MB; Knight TK; Epstein J; Honda DH; Tretiak R
J Manag Care Pharm; 2007 May; 13(4):360-71. PubMed ID: 17506602
[TBL] [Abstract][Full Text] [Related]
14. Use of cost-consequence models in managed care.
Blissenbach HF
Pharmacotherapy; 1995; 15(5 Pt 2):59S-61S. PubMed ID: 8577632
[TBL] [Abstract][Full Text] [Related]
15. Application of pharmacoeconomics to formulary decision making in managed care organizations.
Suh DC; Okpara IR; Agnese WB; Toscani M
Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life as a valid outcome in the treatment of advanced colorectal cancer.
Byrne C; Griffin A; Blazeby J; Conroy T; Efficace F
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S95-104. PubMed ID: 18039559
[TBL] [Abstract][Full Text] [Related]
17. Managed care and physicians' perceptions of drug formulary use.
Fang H; Rizzo JA
Am J Manag Care; 2009 Jun; 15(6):395-400. PubMed ID: 19514805
[TBL] [Abstract][Full Text] [Related]
18. The case for a value-based formulary: striving for total lowest net cost.
Weart W; Bauman GR
Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
[TBL] [Abstract][Full Text] [Related]
19. A health outcomes framework for assessing health status and quality of life: enhanced data for decision making.
Erickson P
J Natl Cancer Inst Monogr; 2004; (33):168-77. PubMed ID: 15504927
[TBL] [Abstract][Full Text] [Related]
20. Managing drug costs: the perception of managed care pharmacy directors.
Litton LM; Sisk FA; Akins ME
Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
